1989
DOI: 10.1002/chin.198928148
|View full text |Cite
|
Sign up to set email alerts
|

ChemInform Abstract: A Synthetic Approach to Rocaglamide via Reductive Cyclization of δ‐Keto Nitriles.

Abstract: ChemInform Abstract Starting with the benzofuranone (I), the nitrile (II) is prepared, which undergoes cyclization upon treatment with samarium diiodide, forming the tricyclic ketone (IV) as the main product. This is converted to the diastereomer (X) of the anticancer agent rocaglamide via the thiolo ester (VII). An alternative route to (X) also involving a SmI2-induced ring closure of a cyanobenzofuranone is described in the original paper.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2010
2010
2012
2012

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(8 citation statements)
references
References 1 publication
0
8
0
Order By: Relevance
“…The synthesis of compounds 4−13 started with the commercially available 6-methylindanone 15, which was deprotonated with NaHMDS and reacted with CS 2 followed by MeI to afford the dithioketenacetal 16 (Scheme 2). 28,36 Compound 16 reacts with guanidine to form an intermediate amino pyrimidine, not shown, that is then oxidized to the corresponding ketone by passing air through the solution to Table 1. Human Functional A 2A and A 1 in Vitro Activity and Reversal of Neuroleptic-Induced Catalepsy in Mice a The in vivo activity of reversing haloperidol-induced catalepsy is reported as an ED 50 , % reversal of at a single dose, or not active at a single dose.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The synthesis of compounds 4−13 started with the commercially available 6-methylindanone 15, which was deprotonated with NaHMDS and reacted with CS 2 followed by MeI to afford the dithioketenacetal 16 (Scheme 2). 28,36 Compound 16 reacts with guanidine to form an intermediate amino pyrimidine, not shown, that is then oxidized to the corresponding ketone by passing air through the solution to Table 1. Human Functional A 2A and A 1 in Vitro Activity and Reversal of Neuroleptic-Induced Catalepsy in Mice a The in vivo activity of reversing haloperidol-induced catalepsy is reported as an ED 50 , % reversal of at a single dose, or not active at a single dose.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
“…The synthesis of compounds 4 – 13 started with the commercially available 6-methylindanone 15 , which was deprotonated with NaHMDS and reacted with CS 2 followed by MeI to afford the dithioketenacetal 16 (Scheme ). , Compound 16 reacts with guanidine to form an intermediate amino pyrimidine, not shown, that is then oxidized to the corresponding ketone by passing air through the solution to give 17 . The amino pyrimidine was protected using excess (Boc) 2 O and 4-(dimethylamino)pyridine (DMAP) to give 18 .…”
Section: Resultsmentioning
confidence: 99%
“…15) (120). Like Taylor ’s approach, the investigators began their synthesis with the known intermediate 126 .…”
Section: Chemical Synthesis Of Cyclopenta[b]benzofuransmentioning
confidence: 99%
“…An earlier attempt to synthesize rocaglamide (1) by Kraus and Sy in 1989 resulted in the synthesis of the di-epi analog of rocaglamide (6) , as shown in Scheme 2 [16]. Michael addition of benzofuranone 2 to cinnamonitrile 3 gave keto-nitrile 4 in a 5 : 1 diastereomeric ratio.…”
Section: Intramolecular Cyclization Approachesmentioning
confidence: 99%
“…Michael addition of the benzofuranone 2 to cinnamaldehyde (11) , followed by SmI 2 -mediated intramolecular pinacolic coupling of ketoaldehyde 12 , gave diols 13a and 13b , which could be separated by chromatography. Swern oxidation of diol 13b yielded ketone 14 , which was converted into β -keto ester 15 using the CS 2 -based procedure as utilized by Kraus and Sy [16]. The keto ester 15 was then converted into ketoamide 16 , followed by a stereoselective reduction with Me 4 NBH(OAc) 3 to give (±)-rocaglamide (1) .…”
Section: Intramolecular Cyclization Approachesmentioning
confidence: 99%